Persistent Asset Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,034
Closed -$819K 120
2025
Q1
$819K Buy
+3,034
New +$819K 0.69% 42